|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Thorne AH, Zanca C and Furnari F:
Epidermal growth factor receptor targeting and challenges in
glioblastoma. Neuro Oncol. 18:914–918. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: Radiotherapy plus concomitant and adjuvant temozolomide
for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Van Meir EG, Hadjipanayis CG, Norden AD,
Shu HK, Wen PY and Olson JJ: Exciting new advances in
neuro-oncology: The avenue to a cure for malignant glioma. CA
Cancer J Clin. 60:166–193. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Furnari FB, Fenton T, Bachoo RM, Mukasa A,
Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, et al:
Malignant astrocytic glioma: Genetics, biology, and paths to
treatment. Genes Dev. 21:2683–2710. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhuang W, Qin Z and Liang Z: The role of
autophagy in sensitizing malignant glioma cells to radiation
therapy. Acta Biochim Biophys Sin (Shanghai). 41:341–351. 2009.
View Article : Google Scholar
|
|
7
|
Wang Y and Jiang T: Understanding high
grade glioma: Molecular mechanism, therapy and comprehensive
management. Cancer Lett. 331:139–146. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shi L, Yuan Y and Li HY: MicroRNA-139-3p
suppresses growth and metastasis of glioblastoma via inhibition of
NIN1/RPNI2 binding protein 1 homolog. Eur Rev Med Pharmacol Sci.
23:4264–4274. 2019.PubMed/NCBI
|
|
11
|
Zuo J, Yu H, Xie P, Liu W, Wang K and Ni
H: miR-454-3p exerts tumor-suppressive functions by down-regulation
of NFATc2 in glioblastoma. Gene. 710:233–239. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang F, Zhang C, Xu C, Fu F, Han D and Li
H: MicroRNA-559 plays an inhibitory role in the malignant
progression of glio-blastoma cells by directly targeting
metadherin. Onco Targets Ther. 12:4415–4426. 2019. View Article : Google Scholar :
|
|
13
|
Zhou X, Wu W, Zeng A, Nie E, Jin X, Yu T,
Zhi T, Jiang K, Wang Y, Zhang J and You Y: MicroRNA-141-3p promotes
glioma cell growth and temozolomide resistance by directly
targeting p53. Oncotarget. 8:71080–71094. 2017.PubMed/NCBI
|
|
14
|
Liu Z, Su D, Qi X and Ma J: MiR-500a-5p
promotes glioblastoma cell proliferation, migration and invasion by
targeting chromodomain helicase DNA binding protein 5. Mol Med Rep.
18:2689–2696. 2018.PubMed/NCBI
|
|
15
|
Cui T, Bell EH, McElroy J, Becker AP,
Gulati PM, Geurts M, Mladkova N, Gray A, Liu K, Yang L, et al:
miR-4516 predicts poor prognosis and functions as a novel oncogene
via targeting PTPN14 in human glioblastoma. Oncogene. 38:2923–2936.
2019. View Article : Google Scholar :
|
|
16
|
Huang SW, Ali ND, Zhong L and Shi J:
MicroRNAs as biomarkers for human glioblastoma: Progress and
potential. Acta Pharmacol Sin. 39:1405–1413. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Banelli B, Forlani A, Allemanni G,
Morabito A, Pistillo MP and Romani M: MicroRNA in glioblastoma: An
overview. Int J Genomics. 2017:76390842017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ahir BK, Ozer H, Engelhard HH and Lakka
SS: MicroRNAs in glioblastoma pathogenesis and therapy: A
comprehensive review. Crit Rev Oncol Hematol. 120:22–33. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen L, Kong G, Zhang C, Dong H, Yang C,
Song G, Guo C, Wang L and Yu H: MicroRNA-432 functions as a tumor
suppressor gene through targeting E2F3 and AXL in lung
adenocarcinoma. Oncotarget. 7:20041–20053. 2016.PubMed/NCBI
|
|
20
|
Lv D, Zhen Z and Huang D: MicroRNA-432 is
downregulated in osteosarcoma and inhibits cell proliferation and
invasion by directly targeting metastasis-associated in colon
cancer-1. Exp Ther Med. 17:919–926. 2019.PubMed/NCBI
|
|
21
|
Jiang N, Chen WJ, Zhang JW, Xu C, Zeng XC,
Zhang T, Li Y and Wang GY: Downregulation of miR-432 activates
Wnt/β-catenin signaling and promotes human hepatocellular carcinoma
proliferation. Oncotarget. 6:7866–7879. 2015.PubMed/NCBI
|
|
22
|
Das E and Bhattacharyya NP: MicroRNA-432
contributes to dopamine cocktail and retinoic acid induced
differentiation of human neuroblastoma cells by targeting NESTIN
and RCOR1 genes. FEBS Lett. 588:1706–1714. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li JB, Liu F, Zhang BP, Bai WK, Cheng W,
Zhang YH and Yu LJ: LncRNA625 modulates prostate cancer cells
proliferation and apoptosis through regulating the Wnt/β-catenin
pathway by targeting miR-432. Eur Rev Med Pharmacol Sci.
21:2586–2595. 2017.PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
25
|
Baradaran Rahimi V, Askari VR, Tajani AS,
Hosseini A and Rakhshandeh H: Evaluation of the sleep-prolonging
effect of lagenaria vulgaris and cucurbita pepo extracts on
pentobar-bital-induced sleep and possible mechanisms of action.
Medicina (Kaunas). 54:pii: E55. 2018.
|
|
26
|
Maris C, D'Haene N, Trépant AL, Le Mercier
M, Sauvage S, Allard J, Rorive S, Demetter P, Decaestecker C and
Salmon I: IGF-IR: A new prognostic biomarker for human
glioblastoma. Br J Cancer. 113:729–737. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shi ZM, Wang XF, Qian X, Tao T, Wang L,
Chen QD, Wang XR, Cao L, Wang YY, Zhang JX, et al: MiRNA-181b
suppresses IGF-1R and functions as a tumor suppressor gene in
gliomas. RNA. 19:552–560. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang Y, Chen X, Lian H, Liu J, Zhou B,
Han S, Peng B, Yin J, Liu W and He X: MicroRNA-503 acts as a tumor
suppressor in glioblastoma for multiple antitumor effects by
targeting IGF-1R. Oncology reports. 31:1445–1452. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Guo T, Feng Y, Liu Q, Yang X, Jiang T,
Chen Y and Zhang Q: MicroRNA-320a suppresses in GBM patients and
modulates glioma cell functions by targeting IGF-1R. Tumour Biol.
35:11269–11275. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang B, Sun F, Dong N, Sun Z, Diao Y,
Zheng C, Sun J, Yang Y and Jiang D: MicroRNA-7 directly targets
insulin-like growth factor 1 receptor to inhibit cellular growth
and glucose metabolism in gliomas. Diagn Pathol. 9:2112014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lian HW, Zhou Y, Jian ZH and Liu RZ:
MiR-323-5p acts as a tumor suppressor by targeting the insulin-like
growth factor 1 receptor in human glioma cells. Asian Pac J Cancer
Prev. 15:10181–10185. 2014. View Article : Google Scholar
|
|
32
|
Lin YC, Hou SC, Hung CM, Lin JN, Chen WC,
Ho CT, Kuo SC and Way TD: Inhibition of the insulin-like growth
factor 1 receptor by CHM-1 blocks proliferation of glioblastoma
multiforme cells. Chem Biol Interact. 231:119–126. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ma Y, Tang N, Thompson RC, Mobley BC,
Clark SW, Sarkaria JN and Wang J: InsR/IGF1R pathway mediates
resistance to EGFR inhibitors in glioblastoma. Clin Cancer Res.
22:1767–1776. 2016. View Article : Google Scholar :
|
|
34
|
Yu J, Wu SW and Wu WP: A tumor-suppressive
microRNA, miRNA-485-5p, inhibits glioma cell proliferation and
invasion by down-regulating TPD52L2. Am J Transl Res. 9:3336–3344.
2017.PubMed/NCBI
|
|
35
|
Xu X, Cai N, Zhi T, Bao Z, Wang D, Liu Y,
Jiang K, Fan L, Ji J and Liu N: MicroRNA-1179 inhibits glioblastoma
cell proliferation and cell cycle progression via directly
targeting E2F transcription factor 5. Am J Cancer Res. 7:1680–1692.
2017.PubMed/NCBI
|
|
36
|
Cheng ZX, Yin WB and Wang ZY: MicroRNA-132
induces temozolomide resistance and promotes the formation of
cancer stem cell phenotypes by targeting tumor suppressor candidate
3 in glioblastoma. Int J Mol Med. 40:1307–1314. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang Y, Cruickshanks N, Pahuski M, Yuan
F, Dutta A, Schiff D, Purow B and Abounader R: Noncoding RNAs in
glioblastoma. Glioblastoma. De Vleeschouwer S: Codon Publications;
Brisbane, AU: 2017, View Article : Google Scholar
|
